CanSino Biologics (HKG:6185, SHA:688185) posted net profit attributable to shareholders of 27.9 million yuan in the third quarter, rising 842% from a year earlier, according to a Monday Hong Kong bourse filing.

Shares of the firm were up nearly 4% in Tuesday afternoon trade.

Earnings per share increased to 0.11 yuan, up 1,000% from the same period last year.

Operating revenue grew nearly 18% year-on-year to 310.2 million yuan.